Van NT - Search Results

1

Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines.

Consoli U, Van NT, Neamati N, Mahadevia R, Beran M, Zhao S, Andreeff M. Consoli U, et al. Among authors: van nt. Leukemia. 1997 Dec;11(12):2066-74. doi: 10.1038/sj.leu.2400511. Leukemia. 1997. PMID: 9447822

2

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.

Engel H, Drach J, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Goodacre A, Andreeff M. Engel H, et al. Among authors: van nt. Leukemia. 1999 Apr;13(4):568-77. doi: 10.1038/sj.leu.2401359. Leukemia. 1999. PMID: 10214863

3

The phosphorylation of retinoblastoma gene product in human myeloid leukemia cells during the cell cycle.

Zhang W, Hittelman W, Van N, Andreeff M, Deisseroth A. Zhang W, et al. Biochem Biophys Res Commun. 1992 Apr 15;184(1):212-6. doi: 10.1016/0006-291x(92)91180-x. Biochem Biophys Res Commun. 1992. PMID: 1567429

4

Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.

Engel H, Goodacre A, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Andreeff M. Engel H, et al. Among authors: van nt. Br J Haematol. 1997 Oct;99(1):64-75. doi: 10.1046/j.1365-2141.1997.3323151.x. Br J Haematol. 1997. PMID: 9359505 Free article.

5

Analysis of nuclear m-AMSA content by DNA fluorochrome competition.

Andersson BS, Beran M, Barlogie B, Van NT, McCredie KB. Andersson BS, et al. Among authors: van nt. Eur J Cancer Clin Oncol. 1986 Jul;22(7):883-9. doi: 10.1016/0277-5379(86)90378-0. Eur J Cancer Clin Oncol. 1986. PMID: 3464432

6

Isolation and characterization of putative intrinsic multidrug resistant Chinese hamster ovary cells by fluorescence activated cell sorting.

Zou CP, Van NT, Kuo MT. Zou CP, et al. Among authors: van nt. Anticancer Res. 1992 Mar-Apr;12(2):427-32. Anticancer Res. 1992. PMID: 1349795

7

Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoprotein.

Bao JJ, Lee BP, Stephens LC, Sahin AA, Van NT, Johnston DA, Ou CN, Kuo MT. Bao JJ, et al. Among authors: van nt. Mol Carcinog. 2000 Oct;29(2):103-11. doi: 10.1002/1098-2744(200010)29:2<103::aid-mc7>3.0.co;2-e. Mol Carcinog. 2000. PMID: 11074607

8

Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress.

Yamane Y, Furuichi M, Song R, Van NT, Mulcahy RT, Ishikawa T, Kuo MT. Yamane Y, et al. Among authors: van nt. J Biol Chem. 1998 Nov 20;273(47):31075-85. doi: 10.1074/jbc.273.47.31075. J Biol Chem. 1998. PMID: 9813007 Free article.

9

Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.

Priebe W, Van NT, Burke TG, Perez-Soler R. Priebe W, et al. Among authors: van nt. Anticancer Drugs. 1993 Feb;4(1):37-48. doi: 10.1097/00001813-199302000-00005. Anticancer Drugs. 1993. PMID: 8457713

10

Flow cytometric analysis of glucocorticoid receptor using monoclonal antibody and fluoresceinated ligand probes.

Marchetti D, Van NT, Gametchu B, Thompson EB, Kobayashi Y, Watanabe F, Barlogie B. Marchetti D, et al. Among authors: van nt. Cancer Res. 1989 Feb 15;49(4):863-9. Cancer Res. 1989. PMID: 2492208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters